PDL BioPharma Inc (NASDAQ:PDLI)

6.98
Delayed Data
As of Feb 27
 +0.03 / +0.43%
Today’s Change
6.52
Today|||52-Week Range
10.26
-9.47%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for PDL BioPharma Inc have a median target of 7.50, with a high estimate of 9.00 and a low estimate of 6.00. The median estimate represents a +7.45% increase from the last price of 6.98.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Hold stock in PDL BioPharma Inc. This rating has held steady since February, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.52
Sales
$140.8M
Reporting Date
Apr 30

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 62.50%
 
 
 
 
 
 
Growthannually 18.28%
 
 
 
 
 
 

Sales

Growthquarterly 20.24%
 
 
 
 
 
 
Growthannually 1.29%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account